Breaking News

Kellman Selected as FSP on Globeimmune Trials

To provide data management and cost containment solutions

Kellman Pharmaceutical Services (KPS) has been selected as a Functional Service Provider (FSP) for GlobeImmune clinical trials. KPS will provide data management and cost containment expertise through data monitoring and reporting.

 

GlobeImmune is a private biopharmaceutical company developing therapeutic vaccines called Tarmogens for the treatment of cancer and infectious diseases.  

 

“We were brought in to provide a more efficient monitoring alternative and are succeeding,” explains KPS President David Kelly. “We look forward to expanding our relationship and scope of services for the company in the future.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters